Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma
{{output}}
Glioblastoma (GBM) is a highly lethal neurological tumor that presents significant challenge for clinicians due to its heterogeneity and high mortality rate. Despite extensive research, there is currently no effective drug treatment available for GBM. Research... ...
